Severe Pertussis in an Infant by Vlkova, Ekaterina & Gospodinova, Margarita Dimova
38 Scripta Scientifica Medica, 2019;51(2):38-40Medical University of Varna
CASE REPORTS
SEVERE PERTUSSIS IN AN INFANT
Ekaterina Vlkova, Margarita Gospodinova
Department of Infectious diseases, Parasitology and Dermatology, Faculty of Medicine, 
Medical University of Varna
Address for correspondence:  
Ekaterina Vlkova
Faculty of Medicine
Medical University of Varna
55 Marin Drinov St
9002 Varna
e-mail: evalkova83@gmail.com
Received: April 22, 2019
Accepted: June 16, 2019
ABSTRACT
Despite high vaccine coverage, pertussis remains a global health concern. Recently, the incidence of infection 
has risen in Europe and other developed countries. Healthcare providers should be aware of the possibility 
of pertussis not only among unvaccinated infants but also among adolescents and adults, in whom pertussis 
often is misdiagnosed.
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Pertussis is a highly contagious, vaccine-
preventable illness caused by Bordetella pertussis (1). 
After a decline in the reported incidence of pertussis 
following the introduction of pertussis vaccines 
into national immunization programmes, reported 
pertussis incidence has increased in recent years in 
Europe (2). Possible reasons for the observed increase 
include changes in diagnostic testing, mismatch of 
vaccine antigens and circulating strains, and reduced 
duration of immunity from acellular pertussis (aP) 
vaccines (3). The most affected age group are infants 
under one year of age, who often show a severe 
clinical course of the disease (2).
A 3-month-old female infant with no past med-
ical history was admitted to the Infectious Diseases 
Department of the St. Marina University Hospital, 
Varna with cough with 1-month duration, posttus-
sive emesis and apnea. She was treated symptomati-
cally in outpatient settings, without clinical improve-
ment. The baby was born at term by Cesarean sec-
tion with no remarkable neonatal events and weighed 
3050 g at birth. She had no history of diphtheria-per-
tussis-tetanus (DPT) vaccination. Her mother had 
prolonged cough before the baby became ill.
On admission, she looked severely ill, with a 
poor mental response and normal body temperature. 
She had paroxysms of whooping cough with perioral 
cyanosis. Auscultation of the lungs revealed bilateral 
diffuse rales. Her respiratory rate was 47 and the pulse 
rate - 130. The remainder of her physical examination 
was normal. Laboratory tests showed leukocytosis 
with absolute lymphocytosis: hemoglobin 101 g/L, 
erythrocytes 3.65x1012/L, leukocytes 19.00x109/L, 
neutrophils 8.50%, basophils 0.10%, monocytes 
10.20%, eosinophils 3.10%, lymphocytes 78.10%, 
platelets 362x1012/L. Compensated respiratory 
acidosis and hypoxemia were revealed: pH 7.392, 
pCO2 6.01 kPa, pO2 6.54 kPa, HCO3 10.72 mmol/L, 
BE  -18.3 mmol/L, O2SAT 85.2 %. C-reactive protein 
level and electrolytes were in normal range. We con-
ducted a chest X-ray to detect lung abnormalities. It 
showed normal results.
We had the following reasons to doubt pertussis 
in this case: paroxysms of whooping cough with peri-
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our patient. Our case shows that better control of the 
disease is needed. Surveillance of pertussis should be 
improved in order to assess the real epidemiological 
situation, especially among adolescents and adults as 
the source of infection for infants.
Since 2009 in Bulgaria whole-cell pertussis 
(wP) vaccines have been replaced by aP vaccines be-
cause of safety concerns. But there are no current 
serosurveys, which assess the duration of immuni-
ty induced by wP and aP vaccines in different age 
groups. Consequently, a question remains open: does 
the vaccination strategy need to be revised and ad-
ditional booster doses administered to adolescents, 
adults and pregnant women?
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oral cyanosis in an unvaccinated infant, who had been 
in contact with her mother who suffered a suspicious 
cough. Polymerase chain reaction (PCR) of the infant’s 
nasopharyngeal secretions was performed and 
showed a positive result for DNA of B. pertussis.
Our patient was treated with azithromycin, 
intravenous fluids, and oxygenation via a face mask. 
As a result of these measures, her clinical condition 
improved quickly, the paroxysms of whooping cough 
were stopped and she was eating the second day after 
admission. The infant was discharged in unremark-
able condition without any neurologic complication 
10 days after admission. The follow-up examinations 
showed no signs of abnormalities in her condition. 
We recommended to continue vaccinations as per 
schedule, but with the baby being given the DT vac-
cine instead of DPT for the remaining doses.
Since 2009, the herd immunity in Bulgaria has 
been supported by five-time shots of the aP vaccine 
(4). Bulgaria is an area with high vaccination cover-
age: 92.1% of the population is vaccinated with three 
doses of aP vaccine. Despite this fact, our coun-
try is experiencing significantly higher numbers of 
pertussis cases. In recent years, the epidemiology of 
pertussis has been changed:  an increasing burden of 
disease among adolescents and adults has been ob-
served in developed countries (2,5,6). In attempt to 
protect infants, additional booster dose for adults 
and maternal immunization have been included in 
the routine immunization schedules in a number of 
European countries and the USA (7,8,9). These mea-
sures show high effectiveness in the reduction of per-
tussis-related morbidity and mortality among in-
fants (10).
In our case, we supposed household transmis-
sion of pertussis from the infant’s mother, who suf-
fered from a prolonged cough, to her daughter. Be-
cause the amount of bacterial DNA in the nasophar-
ynx diminishes after the fourth week of cough (11) 
we did not test the baby’s mother, who reported a 
cough onset 6 weeks prior with full recovery at the 
time of infant’s admission. The clinical presentation 
of pertussis in infants is usually dramatic (9), as was 
observed in our patient: she was administered with 
compensated respiratory acidosis and hypoxemia. 
Early diagnosis and adequate therapeutic measures 
have led to an uncomplicated course of the disease in 
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